The government has published its long-awaited response to the Paterson Inquiry Report. Read the details and what you need to do next in our insight.

This year is likely to see a resurgence of non-Covid trials which have been postponed or paused in the last two years, and new trials for Covid treatments and vaccines (e.g. those based on conventional vaccine technology).

Safety of two medicines (Primodos and Sodium Valproate) and one device (pelvic mesh) was at the heart of the report of the Independent Medicines and Medical Devices Safety Review. Read the latest update on this topic.

In this year’s forward view, we consider issues ranging from fixed recoverable costs in clinical negligence claims, claims resulting from COVID-19 treatment, major inquiries, clinical trials and healthcare technology.

The topic of vicarious liability continues to evolve especially when considered alongside the issue of a non-delegable duty of care in the health setting. Read our top tips on how to deal with this issue.

Welcome to the autumn edition of our Clinical Law Insight. Hospital-acquired Covid-19 infections have been a more significant cause of death than previously appreciated. We consider how you can prepare for claims and for the Public Inquiry due in 2022.

Lack of regulation of non-surgical aesthetic treatments has long been the subject of considerable debate. Now that the APPG has published its report into advanced aesthetic non-surgical cosmetic treatments, will we see changes in the sector?

Welcome to the summer edition of our Clinical Law Insight. We report on recent developments in safety and learning, look ahead towards the Public Inquiry into the government’s response to the pandemic, and recommend actions for Covid-related claims.

To reduce pressure on frontline staff during the pandemic, NHS Resolution has updated the timeline and required safety actions for submissions to the Maternity Incentive Scheme (MIS). We summarise what the scheme entails and its requirements here.

A clinician’s liability to a patient remains limited to the losses falling within the duty of care and not any wider co-incidental losses. The Supreme Court today ruled the scope of duty test generally was applicable to clinical negligence cases.

A joint report prepared by Getting It Right First Time (GIRFT) and NHS Resolution, looking at how claims data can be used effectively to prevent future claims, has been released today.